Dose-escalated simultaneously integrated boost photon or proton therapy in pancreatic cancer in an in-silico study: Gastrointestinal organs remain critical

Campbell, 2009, Classification of R1 resections for pancreatic cancer: the prognostic relevance of tumor involvement within 1 mm of a resection margin, Histopathology, 55, 277, 10.1111/j.1365-2559.2009.03376.x Versteijne, 2020, Preoperative chemoradiotherapy versus immediate surgery of resectable and borderline resectable pancreatic cancer: results of the Dutch randomized phase III PREOPANC trial, J Clin Oncol, 38, 1763, 10.1200/JCO.19.02274 Hammel, 2016, Effect of chemoradiotherapy vs chemotherapy on survival in patients with locally advanced pancreatic cancer controlled after 4 months of gemcitabine with or without erlotinib: the LAP07 randomized clinical trial, JAMA, 315, 1844, 10.1001/jama.2016.4324 Ben-Josef, 2012, A phase I/II trial of intensity modulated radiation (IMRT) dose escalation with concurrent fixed-dose rate gemcitabine (FDR-G) in patients with unresectable pancreatic cancer, Int J Radiat Oncol*Biol*Phys, 84, 1166, 10.1016/j.ijrobp.2012.02.051 Wo, 2014, Phase I study of neoadjuvant accelerated short course radiation therapy with photons and capecitabine for resectable pancreatic cancer, Radiother Oncol, 110, 160, 10.1016/j.radonc.2013.10.027 Herman, 2015, Phase 2 multi‐institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma, Cancer, 121, 1128, 10.1002/cncr.29161 Shaib, 2016, A phase 1 study of stereotactic body radiotherapy dose escalation for borderline resectable pancreatic cancer after modified FOLFIRINOX (NCT01446458), Int J Radiat Oncol Biol Phys, 96, 296, 10.1016/j.ijrobp.2016.05.010 Zschaeck, 2017, Dose-escalated radiotherapy for unresectable or locally recurrent pancreatic cancer: Dose volume analysis, toxicity and outcome of 28 consecutive patients, PLoS One, 12, 10.1371/journal.pone.0186341 Huguet, 2017, Chemotherapy and intensity-modulated radiation therapy for locally advanced pancreatic cancer achieves a high rate of R0 resection*, Acta Oncol, 56, 384, 10.1080/0284186X.2016.1245862 Krishnan, 2016, Focal radiation therapy dose escalation improves overall survival in locally advanced pancreatic cancer patients receiving induction chemotherapy and consolidative chemoradiation, Int J Radiat Oncol*Biol*Phys, 94, 755, 10.1016/j.ijrobp.2015.12.003 Terashima, 2012, A phase I/II study of gemcitabine-concurrent proton radiotherapy for locally advanced pancreatic cancer without distant metastasis, Radiother Oncol, 103, 25, 10.1016/j.radonc.2011.12.029 Sachsman, 2014, Proton therapy and concomitant caspecitabine for non-metastatic unresectable pancreatic adenocarcinoma, Int J Particle Ther, 1, 692, 10.14338/IJPT.14-00006.1 Nichols, 2013, Proton therapy with concomitant capecitabine for pancreatic and ampullary cancers is associated with a low incidence of gastrointestinal toxicity, Acta Oncol, 52, 498, 10.3109/0284186X.2012.762997 Murphy, 2018, Total neoadjuvant therapy with FOLFIRINOX followed by individualized chemoradiotherapy for borderline resectable pancreatic adenocarcinoma: a phase 2 clinical trial, JAMA Oncol, 4, 963, 10.1001/jamaoncol.2018.0329 Murphy, 2019, Total neoadjuvant therapy with FOLFIRINOX in combination with losartan followed by chemoradiotherapy for locally advanced pancreatic cancer: a phase 2 clinical trial, JAMA Oncol, 5, 1020, 10.1001/jamaoncol.2019.0892 Zurlo, 2000, The role of proton therapy in the treatment of large irradiation volumes: a comparative planning study of pancreatic and biliary tumors, Int J Radiat Oncol*Biol*Phys, 48, 277, 10.1016/S0360-3016(00)00522-8 Nichols, 2012, Protons offer reduced normal-tissue exposure for patients receiving postoperative radiotherapy for resected pancreatic head cancer, Int J Radiat Oncol*Biol*Phys, 83, 158, 10.1016/j.ijrobp.2011.05.045 Ding, 2014, Med Dosim, 39, 139, 10.1016/j.meddos.2013.11.005 Thompson, 2014, A dosimetric comparison of proton and photon therapy in unresectable cancers of the head of pancreas: Proton dosimetry in pancreatic cancer, Med Phys, 41, 081711, 10.1118/1.4887797 Lomax, 2008, Intensity modulated proton therapy and its sensitivity to treatment uncertainties 1: the potential effects of calculation uncertainties, Phys Med Biol, 53, 1027, 10.1088/0031-9155/53/4/014 Lomax, 2008, Intensity modulated proton therapy and its sensitivity to treatment uncertainties 2: the potential effects of inter-fraction and inter-field motions, Phys Med Biol, 53, 1043, 10.1088/0031-9155/53/4/015 Lens, 2016, Abdominal organ motion during inhalation and exhalation breath-holds: pancreatic motion at different lung volumes compared, Radiother Oncol, 121, 268, 10.1016/j.radonc.2016.09.012 Dolde, 2019, Comparison of pancreatic motion management with three abdominal corsets for particle radiation therapy: case study, J Appl Clin Med Phys, 20, 111, 10.1002/acm2.12613 Stefanowicz, 2018, Comparison of different treatment planning approaches for intensity-modulated proton therapy with simultaneous integrated boost for pancreatic cancer, Radiat Oncol, 13, 228, 10.1186/s13014-018-1165-0 Marks, 2010, Use of normal tissue complication probability models in the clinic, Int J Radiat Oncol Biol Phys, 76, 10, 10.1016/j.ijrobp.2009.07.1754 Paddick, 2000, A simple scoring ratio to index conformity of radiosurgical treatment plans, J Neurosurg, 93, 219, 10.3171/jns.2000.93.supplement_3.0219 Hsiung-Stripp, 2001, Comparative treatment planning between proton and x-ray therapy in pancreatic cancer, Med Dosim, 26, 255, 10.1016/S0958-3947(01)00072-3 Ben-Josef, 2004, Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancer, Int J Radiat Oncol Biol Phys, 59, 454, 10.1016/j.ijrobp.2003.11.019 Chuong, 2018, Pencil beam scanning versus passively scattered proton therapy for unresectable pancreatic cancer, J Gastrointest Oncol, 9, 687, 10.21037/jgo.2018.03.14 Stefanowicz, 2020, PO – 1063: Do we need a PTV around the boost in simultaneously integrated boost approaches of abdominal tumors?, Radiother Oncol, 152, S564, 10.1016/S0167-8140(21)01080-X Huang, 2012, Dose-volume analysis of predictors for gastrointestinal toxicity after concurrent full-dose gemcitabine and radiotherapy for locally advanced pancreatic cancer, Int J Radiat Oncol Biol Phys, 83, 1120, 10.1016/j.ijrobp.2011.09.022 Olsen, 2017, Predictors of radiation therapy-related gastrointestinal toxicity from anal cancer dose-painted intensity modulated radiation therapy: secondary analysis of NRG Oncology RTOG 0529, Int J Radiat Oncol Biol Phys, 98, 400, 10.1016/j.ijrobp.2017.02.005 Rao, 2017, A novel absorbable radiopaque hydrogel spacer to separate the head of the pancreas and duodenum in radiation therapy for pancreatic cancer, Int J Radiat Oncol Biol Phys, 99, 1111, 10.1016/j.ijrobp.2017.08.006 Komatsu, 2019, Validation of combination treatment with surgical spacer placement and subsequent particle radiotherapy for unresectable hepatocellular carcinoma, J Surg Oncol, 120, 214, 10.1002/jso.25495 Eekers, 2019, Intensity-modulated proton therapy decreases dose to organs at risk in low-grade glioma patients: results of a multicentric in silico ROCOCO trial, Acta Oncol, 58, 57, 10.1080/0284186X.2018.1529424